2022 annual financial data
Revolution Medicines 2022 Operating margin
Revolution Medicines 2022 operating margin with verified reported values.
Direct answer
Operating margin was -730.01%.
Operating income was -258,279,000 USD and net income was -248,705,000 USD.
Operating cash flow was -224,401,000 USD.
Get free Revolution Medicines email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 35,380,000 USD
- Operating income
- -258,279,000 USD
- Net income
- -248,705,000 USD
- Operating cash flow
- -224,401,000 USD